Investment Boom

Cue up "We're in the Money," please, this time for life sciences businesses. Venture Capital funds are flowing freely into the life sciences sector so far this year – up 25 percent by value in the second quarter, according to a new analysis.

The new MoneyTree report from PriceWaterhouse Cooper's and the National Venture Capital Association finds that VCs pumped $2.5 billion into life sciences deals in the second quarter, compared to $2 billion in the same period last year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Raising Money

Another Go-Round?

R&D Concentration

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.